BWB-14627-19226
4 vaccinations
9 coded responses
29 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 919 / CA
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
- 2020-12-27
- 2020-12-28
- 2020-12-30
- 2021-01-05
- 2021-01-12
-
2021-01-15
Dose 2 — Pfizer-BioNTech
-
2021-01-21
Survey response — days 1–6 daily, dose 2MedDRA: Myalgia — Feeling: Good · Site: Pain, Swelling · Muscle or body achesFree text: Had muscle aches x 72 hrs post injection, but now all symptoms have subsidedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-24
-
2021-01-29
Survey response — day 14, dose 2MedDRA: Cough, Rhinorrhoea — Feeling: FairFree text: Cough, nasal drainageMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-06
- 2021-02-14
- 2021-02-21
-
2021-02-28
Survey response — day 42, dose 2MedDRA: Asthma, Cough, Pre-existing disease — Feeling: FairFree text: Dry cough, increased wheezing but have hx of asthma. Unclear what is causing asthma exacerbation.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-16
- 2021-07-16
-
2021-12-20
Dose 3 — Pfizer-BioNTech
- 2022-01-15
- 2022-01-15
-
2022-01-17
Survey response — day 28, dose 3MedDRA: Asthma, Dyspnoea, Wheezing — Feeling: Good · Be unable to do your normal daily activitiesFree text: Increased asthma dyspnea/wheezing.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-24
-
2022-01-31
Survey response — day 42, dose 3MedDRA: Asthma, Cough, Pre-existing disease, Wheezing — Feeling: Good · Be unable to do your normal daily activitiesFree text: Increased asthma symptoms/wheezing, frequent dry cough.MedDRA releases: 2024-11 · check-in free text available
- 2022-03-21
-
2022-06-20
Survey response — 6 months, dose 3MedDRA: Hospitalisation, Impaired work ability, Type 2 diabetes mellitus — Feeling: Good · Be unable to work or attend schoolFree text: New type 2 diabetes as of 5/29/22. Was out of work for 1 week, hospitalized. Doubt this was vaccine related.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-20
Survey response — 12 months, dose 3MedDRA: Cough, Oropharyngeal pain, Pyrexia, Respiratory tract congestion, Respiratory tract infection, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Respiratory illness. Sore throat, cough, congestion, low grade fever. Was covid negative.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-20
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-12-21
Dose 4 — Pfizer-BioNTech
- 2022-12-21
-
2023-01-04
Survey response — day 14, dose 4MedDRA: Anosmia, COVID-19, Cough, Decreased appetite, Dizziness, Dyspnoea, Headache, Pyrexia, Taste disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-01-04
Report sent to call center — day 14, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-01-05
- 2023-01-05
- 2023-01-12
- 2023-01-18
- 2023-01-25
- 2023-02-02
- 2023-03-22
-
2023-06-21
Survey response — 6 months, dose 4MedDRA: Asthma, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-15 | Pfizer-BioNTech | |
| 3 | 2021-12-20 | Pfizer-BioNTech | No |
| 4 | 2022-12-21 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Had muscle aches x 72 hrs post injection, but now all symptoms have subsided
Release 3 — day 14, dose 2
Symptoms: Cough, nasal drainage
Release 4 — day 42, dose 2
Symptoms: Dry cough, increased wheezing but have hx of asthma. Unclear what is causing asthma exacerbation.
Release 10 — day 28, dose 3
Symptoms: Increased asthma dyspnea/wheezing.
Release 11 — day 42, dose 3
Symptoms: Increased asthma symptoms/wheezing, frequent dry cough.
Release 12 — 6 months, dose 3
Symptoms: New type 2 diabetes as of 5/29/22. Was out of work for 1 week, hospitalized. Doubt this was vaccine related.
Release 12 — 12 months, dose 3
Symptoms: Respiratory illness. Sore throat, cough, congestion, low grade fever. Was covid negative.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | · | · | ✓ |
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Impaired work ability | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Respiratory tract infection | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Taste disorder | · | · | ✓ |
| SD | Type 2 diabetes mellitus | · | · | ✓ |
| SD | Wheezing | · | · | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release